PLATINUM-REFRACTORY OVARIAN CARCINOMA
Clinical trials for PLATINUM-REFRACTORY OVARIAN CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PLATINUM-REFRACTORY OVARIAN CARCINOMA trials appear
Sign up with your email to follow new studies for PLATINUM-REFRACTORY OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis is the first study in people to test a new oral medication called NKT3964. The main goals are to find a safe dose and see if the drug shows early signs of shrinking tumors in adults with advanced cancers that have spread and no longer respond to standard treatments. The stud…
Matched conditions: PLATINUM-REFRACTORY OVARIAN CARCINOMA
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Modified virus attacks tough ovarian cancer in new trial
Disease control Recruiting nowThis early-stage trial is testing whether a specially engineered virus called TILT-123, when combined with existing cancer drugs, is safe and potentially effective for women with advanced ovarian cancer that has stopped responding to standard platinum chemotherapy. The virus is d…
Matched conditions: PLATINUM-REFRACTORY OVARIAN CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: TILT Biotherapeutics Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC